• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

甲病毒滴度的测定。

Determination of alphaviral titers.

作者信息

Lundstrom Kenneth

出版信息

Cold Spring Harb Protoc. 2012 Jul 1;2012(7):835-7. doi: 10.1101/pdb.prot070177.

DOI:10.1101/pdb.prot070177
PMID:22753602
Abstract

The alphaviruses Semliki Forest virus and Sindbis virus have been used frequently as expression vectors in vitro and in vivo. Usually, these systems consist of replication-deficient vectors that require a helper vector for packaging of recombinant particles. Replication-proficient vectors have also been engineered. Alphaviral vectors can be used as nucleic-acid-based vectors (DNA and RNA) or infectious particles. The broad host range of alphaviruses facilitates studies in mammalian and nonmammalian cell lines, primary cells in culture, and in vivo. The strong preference for expression in neuronal cells has made alphaviruses particularly useful in neurobiological studies. Unfortunately, their strong cytotoxic effect on host cells, relatively short-term transient expression patterns, and the reasonably high cost of viral production remain drawbacks. However, novel mutant alphaviruses have showed reduced cytotoxicity and prolonged expression. Alphaviruses have also been applied in vaccine development and gene therapy. Before use in vitro or in vivo, it is essential to determine the titer of the generated alphaviral particles. Because defective alphaviruses do not produce plaques, their titers cannot be determined by conventional methods. However, viral titers can be determined readily in cases where the recombinant viruses express reporter genes such as green fluorescent protein or β-galactosidase, as well as indirectly by immunofluorescence methods. The potency of viral stocks can also be evaluated by light microscopic analysis. Alphavirus-infected cells show a dramatic decrease in growth and can be easily distinguished from noninfected control cells through their rounded morphology.

摘要

辛德毕斯病毒和塞姆利基森林病毒等甲病毒常被用作体外和体内的表达载体。通常,这些系统由复制缺陷型载体组成,需要辅助载体来包装重组颗粒。也构建了复制能力强的载体。甲病毒载体可以用作基于核酸的载体(DNA和RNA)或感染性颗粒。甲病毒广泛的宿主范围便于在哺乳动物和非哺乳动物细胞系、培养的原代细胞以及体内进行研究。甲病毒对神经元细胞表达的强烈偏好使其在神经生物学研究中特别有用。不幸的是,它们对宿主细胞的强烈细胞毒性作用、相对短期的瞬时表达模式以及病毒生产的合理高成本仍然是缺点。然而,新型突变甲病毒已显示出降低的细胞毒性和延长的表达。甲病毒也已应用于疫苗开发和基因治疗。在体外或体内使用之前,确定所产生的甲病毒颗粒的滴度至关重要。由于缺陷型甲病毒不产生噬斑,其滴度不能通过常规方法测定。然而,在重组病毒表达报告基因如绿色荧光蛋白或β-半乳糖苷酶的情况下,可以很容易地确定病毒滴度,也可以通过免疫荧光方法间接确定。病毒储备液的效力也可以通过光学显微镜分析来评估。感染甲病毒的细胞生长显著下降,通过其圆形形态可以很容易地与未感染的对照细胞区分开来。

相似文献

1
Determination of alphaviral titers.甲病毒滴度的测定。
Cold Spring Harb Protoc. 2012 Jul 1;2012(7):835-7. doi: 10.1101/pdb.prot070177.
2
Purification and concentration of alphavirus.甲病毒的纯化与浓缩
Cold Spring Harb Protoc. 2012 Jul 1;2012(7):832-4. doi: 10.1101/pdb.prot070169.
3
Generation of recombinant alphaviral vectors.重组甲病毒载体的产生。
Cold Spring Harb Protoc. 2012 Jul 1;2012(7):825-31. doi: 10.1101/pdb.prot070151.
4
In vivo administration of recombinant alphavirus into rodents.将重组甲病毒体内给药至啮齿动物。
Cold Spring Harb Protoc. 2012 Aug 1;2012(8):pdb.prot070581. doi: 10.1101/pdb.prot070581.
5
Delivery of recombinant alphavirus into hippocampal slice tissue culture.将重组甲病毒递送至海马切片组织培养物中。
Cold Spring Harb Protoc. 2012 Aug 1;2012(8):pdb.prot070573. doi: 10.1101/pdb.prot070573.
6
Gene therapy for malignant glioma using Sindbis vectors expressing a fusogenic membrane glycoprotein.使用表达融合性膜糖蛋白的辛德毕斯病毒载体对恶性胶质瘤进行基因治疗。
J Gene Med. 2004 Oct;6(10):1082-91. doi: 10.1002/jgm.605.
7
Alphaviruses: Semliki forest virus and Sindbis virus vectors for gene transfer into neurons.甲病毒:用于将基因导入神经元的辛德毕斯病毒和塞姆利基森林病毒载体
Curr Protoc Neurosci. 2011 Oct;Chapter 4:Unit 4.22. doi: 10.1002/0471142301.ns0422s57.
8
Biology and application of alphaviruses in gene therapy.甲病毒在基因治疗中的生物学特性与应用
Gene Ther. 2005 Oct;12 Suppl 1:S92-7. doi: 10.1038/sj.gt.3302620.
9
Evaluation of recombinant alphaviruses as vectors in gene therapy.重组甲病毒作为基因治疗载体的评估。
Gene Ther. 2000 Mar;7(6):472-80. doi: 10.1038/sj.gt.3301122.
10
Alphaviruses: Semliki Forest virus and Sindbis virus vectors for gene transfer into neurons.甲病毒:用于将基因导入神经元的塞姆利基森林病毒和辛德毕斯病毒载体。
Curr Protoc Neurosci. 2007 Oct;Chapter 4:Unit 4.22. doi: 10.1002/0471142301.ns0422s41.